Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Less Aggressive Ovarian Cancer Treatment Helps Preserve Fertility

By ''
Posted on 25 Aug 2009
Premenopausal women with stage one ovarian cancer who have the cancerous ovary removed have the same five-year survival rates as women who have both ovaries removed, according to a new study.

Researchers at Columbia University (New York, NY, USA) followed 1, 186 women aged 50 or under with stage 1A or 1C epithelial ovarian cancer, and compared 754 women (64%) who underwent bilateral oophorectomy with 432 women (36%) who underwent ovarian preservation; a second analysis examined uterine conservation versus hysterectomy. More...
Multivariate Poisson regression models were developed to describe predictors of fertility preservation, and survival was examined using Cox proportional hazards models and the Kaplan-Meier method.

The results showed that younger age, later year of diagnosis, and residence in the eastern or western United States were associated with ovarian preservation. Women with endometrioid and clear cell histology and stage 1C disease were less likely to have ovarian conservation; the researchers also found that the preservation had no effect on survival. Young age, later year of diagnosis, residence in the eastern or western United States, single women, mucinous tumors, and patients with stage 1A disease were more likely to have uterine preservation; in this multivariate model, uterine preservation also had no effect on survival. The study was published ahead of print on August 10, 2009, in the online edition of the journal Cancer.

"Even if people have completed childbearing, there are some hormonal benefits for maintaining the ovaries. So this is something to consider in women 40 to 50,” said lead author Jason Wright, of the division of gynecologic oncology. "For example, some studies indicate that women who have their ovaries removed before age 55 have a higher risk for cardiovascular disease, dementia and earlier death.”

Related Links:

Columbia University





Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.